The Role of Diabetes and SGLT2 Inhibitors in Cerebrovascular Diseases

National Diabetes Statistics Report Centers for Disease Control. and Prevention2024 [Available from: https://www.cdc.gov/diabetes/php/data-research/index.html

Syed FZ. Type 1 diabetes mellitus. Ann Intern Med. 2022;175(3):Itc33–48.

Article  PubMed  Google Scholar 

Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17).

Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. 2024 heart disease and stroke statistics: A report of US and global data from the American heart association. Circulation. 2024;149(8):e347–913.

Article  PubMed  Google Scholar 

Liu Y, Li J, Dou Y, Ma H. Impacts of type 2 diabetes mellitus and hypertension on the incidence of cardiovascular diseases and stroke in China real-world setting: a retrospective cohort study. BMJ Open. 2021;11(11):e053698.

Article  PubMed  PubMed Central  Google Scholar 

Hu G, Jousilahti P, Sarti C, Antikainen R, Tuomilehto J. The effect of diabetes and stroke at baseline and during follow-up on stroke mortality. Diabetologia. 2006;49(10):2309–16.

Article  PubMed  CAS  Google Scholar 

Madievsky R. Spotlight on antidiabetic agents with cardiovascular or renoprotective benefits. Perm J. 2018;22:18–034.

Article  PubMed  PubMed Central  Google Scholar 

Chen R, Ovbiagele B, Feng W. Diabetes and stroke: epidemiology, pathophysiology, pharmaceuticals and outcomes. Am J Med Sci. 2016;351(4):380–6.

Article  PubMed  PubMed Central  Google Scholar 

Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–22.

Article  PubMed  CAS  Google Scholar 

Khoury JC, Kleindorfer D, Alwell K, Moomaw CJ, Woo D, Adeoye O, et al. Diabetes mellitus: a risk factor for ischemic stroke in a large biracial population. Stroke. 2013;44(6):1500–4.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lau LH, Lew J, Borschmann K, Thijs V, Ekinci EI. Prevalence of diabetes and its effects on stroke outcomes: A meta-analysis and literature review. J Diabetes Investig. 2019;10(3):780–92.

Article  PubMed  Google Scholar 

Lee M, Saver JL, Hong KS, Song S, Chang KH, Ovbiagele B. Effect of pre-diabetes on future risk of stroke: meta-analysis. BMJ. 2012;344:e3564.

Article  PubMed  PubMed Central  Google Scholar 

Mitsios JP, Ekinci EI, Mitsios GP, Churilov L, Thijs V. Relationship between glycated hemoglobin and stroke risk: A systematic review and Meta-Analysis. J Am Heart Assoc. 2018;7(11).

Zhang L, Li X, Wolfe CDA, O’Connell MDL, Wang Y. Diabetes as an independent risk factor for stroke recurrence in ischemic stroke patients: an updated Meta-Analysis. Neuroepidemiology. 2021;55(6):427–35.

Article  PubMed  Google Scholar 

Mao L, Yin R, Yang L, Zhao D. Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis. Front Endocrinol (Lausanne). 2022;13:983723.

Article  PubMed  Google Scholar 

Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013;34(31):2436–43.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Suryavanshi SV, Kulkarni YA. NF-κβ: A potential target in the management of vascular complications of diabetes. Front Pharmacol. 2017;8:798.

Article  PubMed  PubMed Central  Google Scholar 

Yoshida N, Okumura K, Aso Y. High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes. Metabolism. 2005;54(3):345–50.

Article  PubMed  CAS  Google Scholar 

Miyagi T, Ishida A, Shinzato T, Ohya Y. Arterial stiffness is associated with small vessel disease irrespective of blood pressure in Stroke-Free individuals. Stroke. 2023;54(11):2814–21.

Article  PubMed  CAS  Google Scholar 

Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019;18(7):684–96.

Article  PubMed  Google Scholar 

Fujiyoshi A, Suri MFK, Alonso A, Selvin E, Chu H, Guallar E, et al. Hyperglycemia, duration of diabetes, and intracranial atherosclerotic stenosis by magnetic resonance angiography: the ARIC-NCS study. J Diabetes Complications. 2020;34(9):107605.

Article  PubMed  PubMed Central  Google Scholar 

Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan stroke study. Stroke. 1995;26(1):14–20.

Article  PubMed  CAS  Google Scholar 

Arenillas JF, Molina CA, Chacón P, Rovira A, Montaner J, Coscojuela P, et al. High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology. 2004;63(1):27–32.

Article  PubMed  CAS  Google Scholar 

Jiao S, Huang J, Chen Y, Song Y, Gong T, Lu J, et al. Impacts of glycemic control on intracranial plaque in patients with type 2 diabetes mellitus: A vessel wall MRI study. AJNR Am J Neuroradiol. 2021;42(1):75–81.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Krauss RM. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care. 2004;27(6):1496–504.

Article  PubMed  CAS  Google Scholar 

Huxley RR, Filion KB, Konety S, Alonso A. Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol. 2011;108(1):56–62.

Article  PubMed  PubMed Central  Google Scholar 

Seyed Ahmadi S, Svensson AM, Pivodic A, Rosengren A, Lind M. Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study. Cardiovasc Diabetol. 2020;19(1):9.

Article  PubMed  PubMed Central  Google Scholar 

Karam BS, Chavez-Moreno A, Koh W, Akar JG, Akar FG. Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes. Cardiovasc Diabetol. 2017;16(1):120.

Article  PubMed  PubMed Central  Google Scholar 

Choi SE, Sagris D, Hill A, Lip GYH, Abdul-Rahim AH. Atrial fibrillation and stroke. Expert Rev Cardiovasc Ther. 2023;21(1):35–56.

Article  PubMed  CAS  Google Scholar 

Abdel-Qadir H, Gunn M, Lega IC, Pang A, Austin PC, Singh SM, et al. Association of diabetes duration and glycemic control with stroke rate in patients with atrial fibrillation and diabetes: A Population-Based cohort study. J Am Heart Assoc. 2022;11(4):e023643.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Patlolla SH, Lee HC, Noseworthy PA, Wysokinski WE, Hodge DO, Greene EL, et al. Impact of diabetes mellitus on stroke and survival in patients with atrial fibrillation. Am J Cardiol. 2020;131:33–9.

Article  PubMed  PubMed Central  Google Scholar 

Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86.

Article  PubMed  CAS  Google Scholar 

Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–89.

Article  PubMed  CAS 

Comments (0)

No login
gif